Corbus Pharmaceuticals Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:3371 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
06 Mar 25	Sell€40,011	Dominic Smethurst	Individual		6,393	€6.26
20 Sep 24	Buy€6,287,976	Cormorant Asset Management, LP	Company		350,000	€19.96

Insider Trading Volume

Insider Buying: 3371 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 3371?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	2,873	0.0235%
Individual Insiders	40,727	0.333%
General Public	81,133	0.663%
VC/PE Firms	1,172,287	9.58%
Hedge Funds	3,490,000	28.5%
Institutions	7,445,208	60.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.4%.

Top Shareholders

Top 25 shareholders own 88.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.4%	Cormorant Asset Management, LP	2,375,000	€12.1m	0%	0.96%
9.58%	OrbiMed Advisors LLC	1,172,287	€6.0m	28.5%	0.11%
9.12%	Octagon Capital Advisors LP	1,115,000	€5.7m	0%	1.26%
7.14%	BlackRock, Inc.	873,374	€4.5m	8.8%	no data
5.39%	The Vanguard Group, Inc.	659,202	€3.4m	2.1%	no data
4.32%	Adage Capital Management, L.P.	528,937	€2.7m	0%	0.01%
3.52%	RA Capital Management, L.P.	430,182	€2.2m	0%	0.03%
3.27%	Paradigm Biocapital Advisors LP	399,658	€2.0m	0%	0.09%
3.16%	Millennium Management LLC	386,653	€2.0m	276%	no data
3.15%	Altium Capital Management LP	385,000	€2.0m	97.4%	0.77%
2.21%	Prosight Management, LP	270,000	€1.4m	108%	0.48%
2.15%	Geode Capital Management, LLC	263,532	€1.3m	5.51%	no data
1.98%	Tang Capital Management, LLC	242,653	€1.2m	-59.6%	0.08%
1.93%	Armistice Capital LLC	236,000	€1.2m	0%	0.03%
1.87%	State Street Global Advisors, Inc.	228,600	€1.2m	-61.6%	no data
1.36%	Vivo Capital, LLC	166,794	€850.5k	0%	0.07%
1.35%	T. Rowe Price Group, Inc.	164,735	€840.0k	-49.4%	no data
1.33%	Mirae Asset Global Investments Co., Ltd.	162,962	€831.0k	-5.6%	no data
1.31%	Ghost Tree Capital, LLC	160,000	€815.9k	0%	0.42%
1.14%	Renaissance Technologies LLC	139,100	€709.3k	769%	no data
1.1%	Two Sigma Investments, LP	134,175	€684.2k	212%	no data
0.84%	Northern Trust Global Investments	103,264	€526.6k	12.4%	no data
0.8%	Healthinvest Partners AB	98,304	€501.3k	41.3%	0.24%
0.8%	Charles Schwab Investment Management, Inc.	97,882	€499.1k	4.53%	no data
0.73%	UBS Asset Management AG	89,377	€455.8k	269%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/03/31 15:15
End of Day Share Price	2025/03/28 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Corbus Pharmaceuticals Holdings, Inc. is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
George Zavoico	B. Riley Securities, Inc.
Kalpit Patel	B. Riley Securities, Inc.
Kumaraguru Raja	Brookline Capital Markets